Greater Drop in Readmissions With ACA Program Penalties

Share this content:
Greater Drop in Readmissions With ACA Program Penalties
Greater Drop in Readmissions With ACA Program Penalties

TUESDAY, Jan. 3, 2016 (HealthDay News) -- There is a greater reduction in readmission rates at hospitals subject to penalties under the Affordable Care Act's Hospital Readmission Reduction Program (HRRP), according to a study published online Dec. 27 in the Journal of the American Medical Association.

Nihar R. Desai, M.D., M.P.H., from the Yale University School of Medicine in New Haven, Conn., and colleagues compared trends in readmission rates for target and non-target conditions in a retrospective cohort study of Medicare fee-for-service beneficiaries older than 64 years. Data were included for 48,137,102 hospitalizations of 20,351,161 Medicare beneficiaries from 2,214 penalty hospitals and 1,283 non-penalty hospitals.

The researchers found that prior to the HRRP announcement (January 2008 to March 2010), readmission rates were stable across hospitals (except for acute myocardial infarction at non-penalty hospitals). Readmission rates for target and non-target conditions declined significantly faster for patients at hospitals later subject to financial penalties versus those at non-penalized hospitals following announcement of HRRP in March 2010. The decline in readmission rates was significantly faster for target conditions versus non-target conditions for penalty hospitals; readmissions for target conditions declined similarly or more slowly than non-target conditions among non-penalty hospitals. The rate of change for readmission rates plateaued after HRRP implementation in October 2012, with the greatest relative change seen for hospitals subject to financial penalty.

"Medicare fee-for-service patients at hospitals subject to penalties under the HRRP had greater reductions in readmission rates compared with those at non-penalized hospitals," the authors write.

Several authors disclosed financial ties to the pharmaceutical and health care industries.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Parkinson's Add-On Drug Xadago

FDA Approves New Parkinson's Add-On Drug Xadago

To help prevent 'off' episodes among users of levodopa/carbidopa

Infant Mortality Down in United States From 2005 to 2014

Infant Mortality Down in United States From 2005 ...

Largest decreases seen for infants of Asian or Pacific Islander and non-Hispanic black women

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive alveolar recruitment strategy linked to less severe pulmonary complications after cardiac sx

is free, fast, and customized just for you!

Already a member?

Sign In Now »